BioSpace News Archive

Altasciences has completed a Phase I study for the development of gimsilumab, a fully human monoclonal antibody that targets granulocyte-macrophage colony stimulating factor (GM-CSF), found to be up-regulated in SARS CoV-2 in patients with or at risk of developing acute respiratory distress syndrome (ARDS).

Bill Strengthens Home Health Care Access for Seniors and Funds Personal Protective Equipment for Health Care Providers

Sermo, the leading global social platform for physicians and largest healthcare data collection company, today announced the launch of its COVID-19 Real Time Barometer.

AVEO Oncology (NASDAQ: AVEO) and Biodesix, Inc. today announced the discontinuation of their CyFi-2 study, a randomized Phase 2 clinical study evaluating ficlatuzumab, AVEO’s potent hepatocyte growth factor (HGF) inhibitory antibody product candidate, in combination with high-dose cytarabine vs. high-dose cytarabine alone in patients with relapsed and refractory acute myeloid leukemia (AML)

(“Biostage” or the “Company”), a biotechnology company developing next-generation esophageal implants, today announced its financial results for the three and twelve months ended December 31, 2019 .

Syneos Health (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the launch of a Ventilator Initiative.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that the record date and distribution date to our stockholders of shares of Hoth Therapeutics, Inc. (“Hoth”) will be deferred because of the requirement that the shares be registered prior to distribution

The lawsuit alleges Janssen Pharmaceutical’s drug Elmiron is the cause of a Connecticut woman’s eye damage and vision loss

Bruker Corporation (Nasdaq: BRKR) today announced final audited financial results for the fourth quarter and fiscal year 2019, and the filing of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019

The COVID-19 pandemic has created extraordinary challenges across all aspects of healthcare. Many institutions and their brave staff of providers are now focused on caring for patients stricken by the virus.